nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PLA2G4A—schizophrenia	0.816	1	CbGaD
Niflumic Acid—PLA2G1B—blood plasma—schizophrenia	0.00645	0.0867	CbGeAlD
Niflumic Acid—CLCNKA—cerebellum—schizophrenia	0.00457	0.0614	CbGeAlD
Niflumic Acid—PLA2G4A—blood plasma—schizophrenia	0.00393	0.0528	CbGeAlD
Niflumic Acid—SLC16A7—forebrain—schizophrenia	0.00298	0.04	CbGeAlD
Niflumic Acid—SLC16A7—telencephalon—schizophrenia	0.00274	0.0368	CbGeAlD
Niflumic Acid—PLA2G1B—blood—schizophrenia	0.00236	0.0318	CbGeAlD
Niflumic Acid—SLC16A7—gonad—schizophrenia	0.00228	0.0307	CbGeAlD
Niflumic Acid—PLA2G1B—endocrine gland—schizophrenia	0.00205	0.0276	CbGeAlD
Niflumic Acid—SLC16A7—blood—schizophrenia	0.00199	0.0268	CbGeAlD
Niflumic Acid—SLC16A7—midbrain—schizophrenia	0.00197	0.0264	CbGeAlD
Niflumic Acid—PLA2G1B—nervous system—schizophrenia	0.00192	0.0258	CbGeAlD
Niflumic Acid—UGT1A9—endocrine gland—schizophrenia	0.00188	0.0252	CbGeAlD
Niflumic Acid—PLA2G1B—central nervous system—schizophrenia	0.00185	0.0248	CbGeAlD
Niflumic Acid—Leflunomide—CYP1A2—schizophrenia	0.00181	1	CrCbGaD
Niflumic Acid—SLC16A1—telencephalon—schizophrenia	0.00174	0.0234	CbGeAlD
Niflumic Acid—SLC16A7—endocrine gland—schizophrenia	0.00173	0.0232	CbGeAlD
Niflumic Acid—SLC16A7—nervous system—schizophrenia	0.00162	0.0217	CbGeAlD
Niflumic Acid—SLC16A7—central nervous system—schizophrenia	0.00156	0.0209	CbGeAlD
Niflumic Acid—PTGS1—blood plasma—schizophrenia	0.00155	0.0209	CbGeAlD
Niflumic Acid—SLC16A7—cerebellum—schizophrenia	0.00152	0.0204	CbGeAlD
Niflumic Acid—PTGS2—blood plasma—schizophrenia	0.00148	0.0199	CbGeAlD
Niflumic Acid—PLA2G1B—brain—schizophrenia	0.00147	0.0197	CbGeAlD
Niflumic Acid—SLC16A1—gonad—schizophrenia	0.00145	0.0195	CbGeAlD
Niflumic Acid—PLA2G4A—blood—schizophrenia	0.00144	0.0193	CbGeAlD
Niflumic Acid—PLA2G4A—midbrain—schizophrenia	0.00142	0.0191	CbGeAlD
Niflumic Acid—SLC16A1—midbrain—schizophrenia	0.00125	0.0168	CbGeAlD
Niflumic Acid—PLA2G4A—endocrine gland—schizophrenia	0.00125	0.0168	CbGeAlD
Niflumic Acid—SLC16A7—brain—schizophrenia	0.00124	0.0166	CbGeAlD
Niflumic Acid—PLA2G4A—nervous system—schizophrenia	0.00117	0.0157	CbGeAlD
Niflumic Acid—PLA2G4A—central nervous system—schizophrenia	0.00113	0.0151	CbGeAlD
Niflumic Acid—SLC16A1—endocrine gland—schizophrenia	0.0011	0.0148	CbGeAlD
Niflumic Acid—SLC16A1—nervous system—schizophrenia	0.00103	0.0138	CbGeAlD
Niflumic Acid—SLC16A1—central nervous system—schizophrenia	0.000991	0.0133	CbGeAlD
Niflumic Acid—SLC16A1—cerebellum—schizophrenia	0.000968	0.013	CbGeAlD
Niflumic Acid—PLA2G4A—brain—schizophrenia	0.000893	0.012	CbGeAlD
Niflumic Acid—PTGS1—forebrain—schizophrenia	0.00085	0.0114	CbGeAlD
Niflumic Acid—PTGS2—forebrain—schizophrenia	0.000813	0.0109	CbGeAlD
Niflumic Acid—SLC16A1—brain—schizophrenia	0.000786	0.0106	CbGeAlD
Niflumic Acid—PTGS1—telencephalon—schizophrenia	0.000782	0.0105	CbGeAlD
Niflumic Acid—PTGS2—telencephalon—schizophrenia	0.000747	0.01	CbGeAlD
Niflumic Acid—PTGS1—blood—schizophrenia	0.000568	0.00764	CbGeAlD
Niflumic Acid—PTGS2—blood—schizophrenia	0.000543	0.0073	CbGeAlD
Niflumic Acid—PTGS2—midbrain—schizophrenia	0.000537	0.00721	CbGeAlD
Niflumic Acid—PTGS1—endocrine gland—schizophrenia	0.000493	0.00663	CbGeAlD
Niflumic Acid—PTGS2—endocrine gland—schizophrenia	0.000471	0.00633	CbGeAlD
Niflumic Acid—PTGS1—nervous system—schizophrenia	0.000462	0.0062	CbGeAlD
Niflumic Acid—PTGS1—central nervous system—schizophrenia	0.000444	0.00597	CbGeAlD
Niflumic Acid—PTGS2—nervous system—schizophrenia	0.000441	0.00593	CbGeAlD
Niflumic Acid—PTGS2—central nervous system—schizophrenia	0.000425	0.00571	CbGeAlD
Niflumic Acid—PTGS2—cerebellum—schizophrenia	0.000415	0.00558	CbGeAlD
Niflumic Acid—PTGS1—brain—schizophrenia	0.000353	0.00474	CbGeAlD
Niflumic Acid—PTGS2—brain—schizophrenia	0.000337	0.00453	CbGeAlD
Niflumic Acid—PTGS2—Metabolism—PLCH2—schizophrenia	4.84e-05	0.000448	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP26B1—schizophrenia	4.82e-05	0.000446	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GSTM1—schizophrenia	4.79e-05	0.000443	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PLA2G4A—schizophrenia	4.79e-05	0.000443	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR1B—schizophrenia	4.79e-05	0.000443	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—OXT—schizophrenia	4.79e-05	0.000443	CbGpPWpGaD
Niflumic Acid—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—schizophrenia	4.77e-05	0.000441	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IPO5—schizophrenia	4.71e-05	0.000436	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—NDUFV2—schizophrenia	4.62e-05	0.000428	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CACNA1C—schizophrenia	4.62e-05	0.000428	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR1A—schizophrenia	4.61e-05	0.000426	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RTN4—schizophrenia	4.58e-05	0.000423	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RGS4—schizophrenia	4.58e-05	0.000423	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GRM3—schizophrenia	4.58e-05	0.000423	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NDST3—schizophrenia	4.55e-05	0.000421	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—NPS—schizophrenia	4.54e-05	0.00042	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PIK3C2A—schizophrenia	4.51e-05	0.000417	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR6—schizophrenia	4.49e-05	0.000415	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	4.46e-05	0.000412	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR2C—schizophrenia	4.45e-05	0.000411	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—DRD1—schizophrenia	4.45e-05	0.000411	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—schizophrenia	4.44e-05	0.000411	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—APOA1—schizophrenia	4.37e-05	0.000404	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIP4K2A—schizophrenia	4.35e-05	0.000402	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MAG—schizophrenia	4.34e-05	0.000401	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SLC27A5—schizophrenia	4.32e-05	0.000399	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ACSL6—schizophrenia	4.32e-05	0.000399	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	4.31e-05	0.000399	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—DRD3—schizophrenia	4.31e-05	0.000398	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TPH1—schizophrenia	4.3e-05	0.000398	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GCLM—schizophrenia	4.3e-05	0.000398	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MTHFR—schizophrenia	4.23e-05	0.000391	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PIK3C2A—schizophrenia	4.22e-05	0.00039	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—DRD4—schizophrenia	4.18e-05	0.000387	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DAO—schizophrenia	4.12e-05	0.000381	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GAPDH—schizophrenia	4.07e-05	0.000376	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	4.05e-05	0.000375	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PRKD1—schizophrenia	4.04e-05	0.000374	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—SNAP25—schizophrenia	4.04e-05	0.000374	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP2D6—schizophrenia	4.04e-05	0.000374	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CLOCK—schizophrenia	4.03e-05	0.000373	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—APOE—schizophrenia	4.03e-05	0.000372	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CNR1—schizophrenia	3.99e-05	0.000369	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	3.98e-05	0.000368	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CHRM1—schizophrenia	3.97e-05	0.000367	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PNP—schizophrenia	3.95e-05	0.000365	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—APOE—schizophrenia	3.94e-05	0.000364	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP26B1—schizophrenia	3.93e-05	0.000364	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TPH2—schizophrenia	3.93e-05	0.000364	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CACNB2—schizophrenia	3.93e-05	0.000364	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	3.93e-05	0.000363	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR7—schizophrenia	3.9e-05	0.00036	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—DRD2—schizophrenia	3.9e-05	0.00036	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—APOA1—schizophrenia	3.89e-05	0.00036	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—DPYD—schizophrenia	3.87e-05	0.000358	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL3RA—schizophrenia	3.87e-05	0.000358	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NRG3—schizophrenia	3.77e-05	0.000349	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TLE1—schizophrenia	3.77e-05	0.000349	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GFAP—schizophrenia	3.73e-05	0.000345	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GRM5—schizophrenia	3.69e-05	0.000341	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—NDUFV2—schizophrenia	3.67e-05	0.000339	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP1A2—schizophrenia	3.66e-05	0.000338	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—TH—schizophrenia	3.6e-05	0.000333	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CACNA1C—schizophrenia	3.6e-05	0.000333	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TLE3—schizophrenia	3.57e-05	0.00033	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—schizophrenia	3.51e-05	0.000325	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TPH1—schizophrenia	3.5e-05	0.000324	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GCLM—schizophrenia	3.5e-05	0.000324	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PIK3C2A—schizophrenia	3.5e-05	0.000324	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIP4K2A—schizophrenia	3.45e-05	0.000319	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP1A2—schizophrenia	3.42e-05	0.000316	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCK—schizophrenia	3.37e-05	0.000312	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GAPDH—schizophrenia	3.37e-05	0.000312	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CLOCK—schizophrenia	3.34e-05	0.000309	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—APOE—schizophrenia	3.34e-05	0.000308	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	3.32e-05	0.000307	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	3.3e-05	0.000306	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	3.3e-05	0.000305	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PRKD1—schizophrenia	3.29e-05	0.000305	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PDE4B—schizophrenia	3.29e-05	0.000304	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TPH2—schizophrenia	3.26e-05	0.000301	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CACNB2—schizophrenia	3.26e-05	0.000301	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—EP300—schizophrenia	3.24e-05	0.0003	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CCKAR—schizophrenia	3.23e-05	0.000299	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—DPYD—schizophrenia	3.21e-05	0.000296	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP2D6—schizophrenia	3.14e-05	0.000291	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—SNAP25—schizophrenia	3.14e-05	0.000291	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADORA2A—schizophrenia	3.14e-05	0.00029	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP26B1—schizophrenia	3.12e-05	0.000289	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TP53—schizophrenia	3.1e-05	0.000287	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—COMT—schizophrenia	3.06e-05	0.000283	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTP1—schizophrenia	3.05e-05	0.000282	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MAOA—schizophrenia	3.04e-05	0.000281	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FGA—schizophrenia	3.01e-05	0.000278	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CACNA1C—schizophrenia	2.98e-05	0.000276	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—AKT1—schizophrenia	2.95e-05	0.000273	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—schizophrenia	2.95e-05	0.000272	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NPY—schizophrenia	2.93e-05	0.000271	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NOTCH4—schizophrenia	2.93e-05	0.000271	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ATP2A2—schizophrenia	2.93e-05	0.000271	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PIK3C2A—schizophrenia	2.9e-05	0.000269	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NRG3—schizophrenia	2.89e-05	0.000267	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TLE1—schizophrenia	2.89e-05	0.000267	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ABCB1—schizophrenia	2.89e-05	0.000267	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP1A2—schizophrenia	2.84e-05	0.000263	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—OXT—schizophrenia	2.83e-05	0.000261	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR1B—schizophrenia	2.83e-05	0.000261	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TH—schizophrenia	2.8e-05	0.000259	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PLA2G4A—schizophrenia	2.8e-05	0.000259	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GSTM1—schizophrenia	2.8e-05	0.000259	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TPH1—schizophrenia	2.78e-05	0.000257	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GCLM—schizophrenia	2.78e-05	0.000257	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GAPDH—schizophrenia	2.75e-05	0.000254	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TLE3—schizophrenia	2.74e-05	0.000253	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—HTR2A—schizophrenia	2.73e-05	0.000252	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CLOCK—schizophrenia	2.73e-05	0.000252	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR1A—schizophrenia	2.72e-05	0.000252	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOE—schizophrenia	2.72e-05	0.000251	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	2.69e-05	0.000249	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NPS—schizophrenia	2.68e-05	0.000248	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CACNB2—schizophrenia	2.66e-05	0.000246	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TPH2—schizophrenia	2.66e-05	0.000246	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR2C—schizophrenia	2.63e-05	0.000243	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DRD1—schizophrenia	2.63e-05	0.000243	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—schizophrenia	2.62e-05	0.000243	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PRKD1—schizophrenia	2.62e-05	0.000242	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—DPYD—schizophrenia	2.61e-05	0.000242	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—GAPDH—schizophrenia	2.61e-05	0.000241	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP2D6—schizophrenia	2.6e-05	0.000241	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—SNAP25—schizophrenia	2.6e-05	0.000241	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NTRK2—schizophrenia	2.56e-05	0.000236	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DRD3—schizophrenia	2.55e-05	0.000235	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—EP300—schizophrenia	2.52e-05	0.000233	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—schizophrenia	2.48e-05	0.000229	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DRD4—schizophrenia	2.47e-05	0.000228	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CACNA1C—schizophrenia	2.43e-05	0.000225	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—schizophrenia	2.39e-05	0.000221	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—COMT—schizophrenia	2.38e-05	0.00022	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTP1—schizophrenia	2.37e-05	0.000219	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PIK3C2A—schizophrenia	2.37e-05	0.000219	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MAOA—schizophrenia	2.37e-05	0.000219	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CNR1—schizophrenia	2.36e-05	0.000218	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP1A2—schizophrenia	2.36e-05	0.000218	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TH—schizophrenia	2.32e-05	0.000215	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TP53—schizophrenia	2.32e-05	0.000214	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOE—schizophrenia	2.31e-05	0.000213	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FGA—schizophrenia	2.3e-05	0.000213	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR7—schizophrenia	2.3e-05	0.000213	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DRD2—schizophrenia	2.3e-05	0.000213	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—EP300—schizophrenia	2.29e-05	0.000212	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—APOA1—schizophrenia	2.28e-05	0.000211	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—EP300—schizophrenia	2.24e-05	0.000208	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ABCB1—schizophrenia	2.24e-05	0.000208	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GAPDH—schizophrenia	2.18e-05	0.000202	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GSTM1—schizophrenia	2.18e-05	0.000201	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PRL—schizophrenia	2.17e-05	0.000201	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CLOCK—schizophrenia	2.16e-05	0.0002	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOE—schizophrenia	2.16e-05	0.0002	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—APOA1—schizophrenia	2.13e-05	0.000197	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—SNAP25—schizophrenia	2.12e-05	0.000196	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP2D6—schizophrenia	2.12e-05	0.000196	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TPH2—schizophrenia	2.11e-05	0.000195	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CACNB2—schizophrenia	2.11e-05	0.000195	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—schizophrenia	2.11e-05	0.000195	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—DPYD—schizophrenia	2.07e-05	0.000192	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—S100B—schizophrenia	2.03e-05	0.000187	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SNAP25—schizophrenia	2.01e-05	0.000186	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—COMT—schizophrenia	1.97e-05	0.000183	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTP1—schizophrenia	1.96e-05	0.000182	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MAOA—schizophrenia	1.96e-05	0.000181	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—AKT1—schizophrenia	1.96e-05	0.000181	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ERBB4—schizophrenia	1.94e-05	0.000179	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CACNA1C—schizophrenia	1.93e-05	0.000178	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—schizophrenia	1.93e-05	0.000178	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP1A2—schizophrenia	1.92e-05	0.000178	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.9e-05	0.000176	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TH—schizophrenia	1.89e-05	0.000175	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PIK3C2A—schizophrenia	1.88e-05	0.000174	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ABCB1—schizophrenia	1.86e-05	0.000172	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—HSPA1A—schizophrenia	1.81e-05	0.000167	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PLA2G4A—schizophrenia	1.81e-05	0.000167	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GSTM1—schizophrenia	1.81e-05	0.000167	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TP53—schizophrenia	1.8e-05	0.000167	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NOS1—schizophrenia	1.79e-05	0.000166	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOE—schizophrenia	1.79e-05	0.000166	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NRG1—schizophrenia	1.79e-05	0.000165	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—schizophrenia	1.78e-05	0.000165	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MEF2C—schizophrenia	1.77e-05	0.000164	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—APOA1—schizophrenia	1.77e-05	0.000164	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—YWHAZ—schizophrenia	1.71e-05	0.000158	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP2D6—schizophrenia	1.69e-05	0.000156	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—SNAP25—schizophrenia	1.69e-05	0.000156	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ERBB3—schizophrenia	1.68e-05	0.000155	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PRL—schizophrenia	1.66e-05	0.000154	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—HTR2A—schizophrenia	1.61e-05	0.000149	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—COMT—schizophrenia	1.61e-05	0.000149	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTP1—schizophrenia	1.6e-05	0.000148	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MAOA—schizophrenia	1.6e-05	0.000148	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—schizophrenia	1.6e-05	0.000148	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.55e-05	0.000143	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP1A2—schizophrenia	1.52e-05	0.000141	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—AKT1—schizophrenia	1.52e-05	0.000141	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ABCB1—schizophrenia	1.52e-05	0.00014	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TH—schizophrenia	1.5e-05	0.000139	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOE—schizophrenia	1.5e-05	0.000139	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOE—schizophrenia	1.49e-05	0.000137	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ERBB4—schizophrenia	1.48e-05	0.000137	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—APOA1—schizophrenia	1.48e-05	0.000137	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GSTM1—schizophrenia	1.47e-05	0.000136	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PLA2G4A—schizophrenia	1.47e-05	0.000136	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—APOA1—schizophrenia	1.47e-05	0.000136	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ESR1—schizophrenia	1.43e-05	0.000132	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NRG1—schizophrenia	1.37e-05	0.000127	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—AKT1—schizophrenia	1.36e-05	0.000125	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—EP300—schizophrenia	1.31e-05	0.000121	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—YWHAZ—schizophrenia	1.31e-05	0.000121	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—schizophrenia	1.3e-05	0.00012	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—GSK3B—schizophrenia	1.3e-05	0.00012	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ERBB3—schizophrenia	1.28e-05	0.000119	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—COMT—schizophrenia	1.28e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTP1—schizophrenia	1.27e-05	0.000118	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MAOA—schizophrenia	1.27e-05	0.000117	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—schizophrenia	1.23e-05	0.000114	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—EP300—schizophrenia	1.23e-05	0.000114	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOE—schizophrenia	1.21e-05	0.000112	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ABCB1—schizophrenia	1.2e-05	0.000111	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—APOA1—schizophrenia	1.2e-05	0.000111	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PLA2G4A—schizophrenia	1.17e-05	0.000108	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GSTM1—schizophrenia	1.17e-05	0.000108	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOE—schizophrenia	1.15e-05	0.000106	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—APOA1—schizophrenia	1.13e-05	0.000105	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—schizophrenia	1.03e-05	9.55e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—EP300—schizophrenia	1.02e-05	9.45e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—GSK3B—schizophrenia	9.94e-06	9.19e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOE—schizophrenia	9.61e-06	8.89e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—APOA1—schizophrenia	9.5e-06	8.79e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—AKT1—schizophrenia	8.74e-06	8.08e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—EP300—schizophrenia	8.54e-06	7.9e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—EP300—schizophrenia	8.46e-06	7.83e-05	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—AKT1—schizophrenia	7.94e-06	7.34e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—EP300—schizophrenia	6.9e-06	6.38e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—EP300—schizophrenia	6.54e-06	6.05e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—AKT1—schizophrenia	6.17e-06	5.71e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TP53—schizophrenia	6.11e-06	5.65e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—EP300—schizophrenia	5.48e-06	5.07e-05	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—AKT1—schizophrenia	5.16e-06	4.77e-05	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—AKT1—schizophrenia	5.12e-06	4.73e-05	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—AKT1—schizophrenia	4.17e-06	3.86e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—AKT1—schizophrenia	3.95e-06	3.65e-05	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—AKT1—schizophrenia	3.31e-06	3.06e-05	CbGpPWpGaD
